6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Latest Press Releases

Time	Headline
14m ago	Timberland Bancorp Reports Second Fiscal Quarter Net Income of $7.1 Million
40m ago	CPKC increases dividend by 17.5 percent
41m ago	Waldencast announces conclusion of SEC investigation
41m ago	Nektar to Announce Financial Results for the First Quarter on Thursday, May 7, 2026, After Close of U.S.-Based Financial Markets
42m ago	F5 to Host Analyst and Investor Meeting on May 28, 2026

About

Apellis Pharmaceuticals Inc (NASDAQ:APLS) — investor relations, events, news, and company updates on 6ix.

Latest News

Biogen to Acquire Apellis, Enhancing the Company’s Growth Portfolio in Immunology and Rare Disease, Bolstering Growth Outlook and Accelerating Expansion into Nephrology

Apellis Announces Mikael Dolsten, M.D., Ph.D., to Join Board of Directors

Apellis Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results

Apellis Pharmaceuticals to Present at the TD Cowen 46th Annual Health Care Conference

Apellis Announces Eight Oral Presentations at the 49th Macula Society Annual Meeting

Financials

Revenue

$1 B

Market Cap

$5.17 B

P/E Ratio

224.50

EPS

0.18

Community Chat

Ask AI

Originaltext

Diese Übersetzung bewerten

Mit deinem Feedback können wir Google Übersetzer weiter verbessern